ENTITY
Bridgebio Pharma Inc

Bridgebio Pharma Inc (BBIO US)

22
Analysis
Health Care • United States
Bridgebio Pharma, Inc. operates as a bio technology company. The Company focuses on development of medicines for genetic diseases. Bridgebio Pharma serves patients worldwide.
more
Exchange Announcement • 13 Oct 2026 18:01

Current Report (Form 8-K | Period ending 2026-10-06)

Exchange Announcement • 17 Aug 2026 21:05

Current Report (Form 8-K | Period ending 2026-08-13)

Exchange Announcement • 14 Aug 2026 18:50

424B7 | Prospectus

Exchange Announcement • 11 Aug 2026 04:31

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 11 Aug 2026 04:03

Current Report (Form 8-K | Period ending 2026-08-10)

x